Angiopoietin-1 (Ang1) is a strong apoptosis survival factor for endothelial cells. In this study, the receptor/second messenger signal transduction pathway for the antiapoptotic effect of Ang1 on human umbilical vein endothelial cells was examined. Pretreatment with soluble Tie2 receptor, but not Tie1 receptor, blocked the Ang1-induced antiapoptotic effect. Ang1 induced phosphorylation of Tie2 and the p85 subunit of phosphatidylinositol 3Ј-kinase (PI 3Ј-kinase) and increased PI 3Ј-kinase activity in a dose-dependent manner. The PI 3Ј-kinase-specific inhibitors wortmannin and LY294002 blocked the Ang1-induced antiapoptotic effect. Ang1 induced phosphorylation of the serine-threonine kinase Akt at Ser473 in a PI 3Ј-kinase-dependent manner. Expression of a dominant-negative form of Akt reversed the Ang1-induced antiapoptotic effect. Ang1 mRNA and protein were present in vascular smooth muscle cells but not in endothelial cells. Cultured vascular smooth muscle cells, but not human umbilical vein endothelial cells, secreted Ang1. These findings indicate that the Tie2 receptor, PI 3Ј-kinase, and Akt are crucial elements in the signal transduction pathway leading to endothelial cell survival induced by the paracrine activity of Ang1. (Circ Res. 2000;86:24-29.) 
V ascular endothelium, a monolayer of cells lining the intima of the blood vessels, is involved in vascular permeability, vascular tonus, coagulation, vascular remodeling, and other functions. 1 Endothelial cells directly contact the plasma and cellular components of the blood and are the targets of many cytokines and growth factors. 2, 3 Apoptosis, a process for eliminating unwanted cells, is involved in the regulation of cell number under physiological and certain pathological conditions. 4 Apoptosis in vascular endothelial cells is prevented by several growth factors and cytokines, such as fibroblast growth factor, 5 vascular endothelial growth factor (VEGF), 6 and endothelin-1. 7 These molecules not only suppress apoptosis but also stimulate cell proliferation, thereby maintaining or increasing cell number.
Angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2) have recently been identified as ligands of the endothelial cell-specific Tie2 receptor. 8, 9 In vivo analyses by targeted gene inactivation and transgenic overexpression reveal that Ang1 recruits and sustains periendothelial support cells. 10 Ang2 disrupts blood vessel formation in the developing embryo by antagonizing the effects of Ang1 on Tie2. 9 Interestingly, transgenic overexpression 11 or gene transfer 12 of Ang1 increases vascularization in vivo. In vitro experiments have shown that Ang1 has specific effects on endothelial cells; it has little effect on proliferation, but it potently induces sprouting, 13, 14 chemotactic response, 15 and network formation. 16 Also, Ang1 is a strong apoptosis survival factor in endothelial cells under serum deprivation. 16 -18 Because Ang1 does not have proliferative activity in endothelial cells, 8, 14 we conclude that the antiapoptotic effect of Ang1 is the result of an enhancement of cell survival, not proliferation. However, it is not known how Ang1 affects cell survival. The phosphatidylinositol 3Ј-kinase (PI 3Ј-kinase) and Akt pathways are common features in the signal transduction of the antiapoptotic effects of growth factors. 19 Recently, Kontos et al 20 demonstrated that Tie2 activates PI 3Ј-kinase and Akt. They suggested that this receptor/ intracellular signaling system might account for endothelial cell survival. However, their findings did not include Ang1 stimulation.
In this study, we examined the receptor/second messenger signal transduction pathway for the antiapoptotic effect of Ang1 on human umbilical vein endothelial cells (HUVECs). We found that the Tie2 receptor and the PI 3Ј-kinase/Akt signal transduction pathway are crucial elements in the processes leading to endothelial cell survival induced by Ang1. ticals, Inc. Ang1* is a recombinant version of Ang1 with modified NH 2 -terminus and mutated Cys 245 . 9 Ang1* is easier to produce and purify. Mutation of the Cys 245 in Ang1, which is not shared between Ang1 and Ang2, does not alter its agonistic properties. Biological activity of recombinant Ang1 and Ang1* is similar, confirmed by their high-affinity binding to and stimulation of the Tie2 receptor in vitro. 9 Recombinant human VEGF 165 was purchased from R&D systems. Media and sera were purchased from Life Technology, Inc. All other reagents were purchased from Sigma, unless otherwise specified. HUVECs and human umbilical vascular smooth muscle cells (HUVSMCs) were prepared and grown as described previously. 14 Murine endothelial cell line MS1 (CRL-2279, American Type Culture Collection) was grown in the same manner as HUVECs. Mammalian expression vector containing the Lys179Met dominantnegative mutant of Akt (Akt1) cDNA (Upstate Biotechnology, Inc) or its control empty vector (Upstate Biotechnology, Inc) was transfected into MS1 cells using LipofectAMINE Plus (Gibco-BRL) and incubated for 24 hours in M-199 medium with 10% FBS. To induce apoptosis, a serum deprivation method was used as described previously. 17
Determination of Apoptosis
We used 3 methods to determine apoptosis. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays were performed on the floating and adherent cells according to the manufacturer's protocol (Oncor). Nuclear staining with Sytox Green (Boehringer Mannheim) was performed. DNA laddering was examined using 1.5% agarose gels containing ethidium bromide. Genomic DNAs were extracted from both floating and adherent endothelial cells using NP-40 lysis. 21 Quantification of apoptosis was performed as described previously. 17
Phosphorylation Assays of Tie2 Receptor, p85 Subunit of PI 3-Kinase, and Akt
HUVECs were seeded to 6-well plates or 10-cm dishes at a density of 5ϫ10 4 cells/cm 2 and were grown in M-199 with 10% FBS for 24 hours. After 24 hours of serum deprivation, the medium was changed to serum-free M-199 containing wortmannin where indicated. Two hours later, Ang1* was added to the cells at the indicated amounts, and the cells were incubated for the indicated times. A phosphory- Figure 1 . Effect of Ang1* on serum deprivation-induced apoptosis in HUVECs. Ang1* (200 ng/mL) or control buffer was added to cells after changing to serumfree medium. Apoptosis was assayed 24 hours after serum deprivation. A, Phasecontrast microscopy. Note that there are fewer adherent cells and more floating cells in the serum-deprived (SD) culture than in the control with 10% serum. Cells exposed to Ang1* are more adherent than cells in the SD culture. Magnification, ϫ200. B, Light microscopy of TUNEL assay. C, Fluorescence microscopy of Sytox Green staining. Arrowheads or arrows indicate brown or yellow apoptotic cells with fragmented or condensed DNA. Magnification, ϫ400. D, Agarose gel electrophoresis. DNA from SD cells has notable DNA laddering, whereas DNA from control cells (CT) shows no DNA laddering. DNA from cells exposed to Ang1* (SA) shows reduced DNA laddering compared with that of SD cells. MM indicates -HindIII molecular weight marker. lation assay of the Tie2 or p85 subunit of PI 3Ј-kinase was performed with anti-Tie2 antibody (Santa Cruz Biotechnology) or anti-p85 subunit of PI 3Ј-kinase (Upstate Biotechnology, Inc) according to the method described by Maisonpierre et al 9 and Hu et al. 22 The Akt (Ser473) phosphorylation assay was performed according to the manufacturer's protocol (New England BioLabs). PI 3Ј-kinase activity was measured according to the method described by Hu et al. 22
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis
RT-PCR was performed with specific primers for either Ang1 (sense, 5Ј-GGCAGTACAATGACAGTTTC-3Ј; antisense, 5Ј-CTTTGTTGCTTTCATAATCGC-3Ј) or ␤-actin (sense, 5Ј-ATCTGGCACCACACCTTCTACAATGAGCTGCG-3Ј; antisense, 5Ј-CGTCATACTCCTGCTTGCTGATCCACATCTGC-3Ј) in total RNA (100 ng) from HUVSMCs or HUVECs as described previously. 14
Detection of Ang1 in Tissue Sections and Culture Medium
Polyclonal anti-Ang1 antibody was produced by immunization of rabbits using standard methods with a recombinant NH 2 -terminal portion of Ang1 protein (amino acids, 53 to 246) produced in Escherichia coli. Immunohistochemistry was performed in human umbilical cords, normal human uterine cervix, and pig hearts as described previously. 23 Serum-free defined medium (100 mL) that was on confluent HUVSMCs or HUVECs for 24 hours was incubated with 5 g of rTie2-Fc for 1 hour at room temperature. Ang1/rTie2-Fc complexes were recovered on protein A-Sepharose beads, and Ang1 was determined by Western blotting with anti-Ang1 antibody.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results

Ang1* Blocks Apoptosis in Endothelial Cells Through Tie2 Receptor Binding
Serum deprivation caused apoptosis in HUVECs, evidenced by more floating and less adherent cells seen with phasecontrast microscopy ( Figure 1A) , fragmented DNA detected with TUNEL assay ( Figure 1B) , condensed or fragmented nuclei in cells stained with Sytox Green ( Figure 1C ), and increased DNA laddering ( Figure 1D ). Approximately 30% of total cells undergo apoptosis during serum deprivation at 24 hours after serum deprivation (Figures 1 and 2) . The proportion of floating apoptotic cells to total apoptotic cells was Ϸ45% to 50%. Similarly to our previous report, 17 Ang1* at 200 ng/mL inhibited Ϸ55% to 60% of the apoptotic events ( Figure 2 ). A 5-fold molar excess (2 g/mL) of rTie2-Fc, but not of rTie1-Fc, completely blocked the antiapoptotic effect of Ang1* (Figure 2 ). These results indicate that Ang1 exerts its antiapoptotic effect in endothelial cells through Tie2 receptor binding, but not through Tie1.
Ang1* Induces Phosphorylation of Tie2 and p85 Subunit of PI 3-Kinase and Increases PI 3-Kinase Activity in HUVECs
The protein level of the Tie2 receptor in HUVECs decreased slightly at 24 hours after serum deprivation ( Figure 3A) . Western blot analysis of the Tie2 protein in 50 g of total protein from cell lysates at 0, 12, and 24 hours after serum deprivation. B and C, Phosphorylation assays of Tie2 and p85 subunit of PI 3Ј-kinase, respectively. Cells were incubated for 24 hours in serum-free medium before Ang1* addition. Indicated amounts of Ang1* were added to cells and incubated for 10 minutes. Cell lysates were immunoprecipitated with corresponding antibodies and separated by SDS-PAGE. After Western blotting with antiphosphotyrosine antibody (top), the membranes were stripped and reincubated with corresponding antibodies (bottom) for detection of total Tie2 or p85 protein. D, Autoradiogram of thin-layer chromatography for PI 3Ј-kinase activity. Cells exposed to Ang1* for 10 minutes generated phosphatidylinositol-3-monophosphate (PIP) in a dosedependent manner. Results from 3 experiments were similar. E, Densitometric analysis shows the relative ratios of phosphorylated Tie2/total Tie2, phosphorylated p85/total p85, and PIP/origin. The ratio for the control is arbitrarily presented as 1. Data are meanϮSE of the ratios from 3 experiments.
Under these conditions, Ang1* induced the phosphorylation of Tie2 ( Figure 3B ) and the p85 subunit of PI 3Ј-kinase ( Figure 3C ) in a dose-dependent manner. Ang1* increased PI 3Ј-kinase activity in a dose-dependent manner ( Figure 3D) . Thus, the Ang1*-induced antiapoptotic effect may be mediated through activation of the Tie2 receptor and PI 3Ј-kinase.
Ang1*-Induced Antiapoptotic Effect in HUVECs Is Mediated by PI 3-Kinase
Two specific inhibitors of PI 3Ј-kinase, wortmannin and LY294002, almost completely blocked the Ang1*-induced antiapoptotic effect (Figure 4 ). Both reagents slightly enhanced the degree of apoptosis observed in the absence of Ang1*, possibly because of inhibition of basal PI 3Ј-kinase activity present in serum-deprived cells. In addition, wortmannin also completely blocked the VEGF 165 -induced antiapoptotic effect (Figure 4) . These results suggest that Ang1, like VEGF 165 , exerts its antiapoptotic effect in endothelial cells through a PI 3Ј-kinase-mediated pathway.
Akt Activation Is Involved in the Antiapoptotic Effect of Ang1*
To examine whether Akt activation is involved in the antiapoptotic effect of Ang1*, Akt phosphorylation at Ser473 was examined in whole-cell lysates of HUVECs by means of a phosphospecific antibody. In initial time course experiments, 
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Angiopoietin-1 Antiapoptotic Pathway Ang1* caused maximal activation of Akt in 20 to 30 minutes through the phosphorylation of Ser473. The response gradually decreased after prolonged incubation (data not shown). Ang1* increased Akt phosphorylation at Ser473 in a dosedependent manner ( Figure 5A ). Densitometric analysis of the signals revealed that Akt phosphorylation was 8.8-fold higher in HUVECs treated with 200 ng/mL of Ang1* ( Figure 5B) . The PI 3Ј-kinase inhibitor wortmannin completely abolished Akt activation in response to Ang1* ( Figure 5A and 5B) . It is known that the expression of Lys179Met Akt mutant causes a loss of Akt kinase activity with a dominant-negative effect on endogenous Akt. 24 We chose the MS1 cell line because it expresses the Tie2 receptor assessed by Western blot analysis, and we were able to achieve a transfection efficiency of Ϸ60%, assessed by immunofluorescent detection of the tagged protein of Lys179Met Akt mutant, c-Myc, with anti-c-Myc antibody (Invitrogen) (data not shown). MS1 endothelial cells transfected with Lys179Met Akt mutant showed an Ang1*-induced antiapoptotic effect, but the degree of antiapoptotic effect was significantly less than that in the cells transfected with control vector (Figure 6 ). Thus, Ang1*-induced endothelial cell survival is mediated by PI 3Ј-kinase through Akt phosphorylation at Ser473.
Ang1 May Exert Its Antiapoptotic Effect in Endothelial Cells by Paracrine Action
Ang1 mRNA is mainly present in periendothelial cells, including vascular smooth muscle, 8, 10 whereas Tie2 is mainly present in endothelial cells. 25 RT-PCR revealed the correctly sized PCR product for Ang1 (1581 bp) in HUVSMCs, but not in HUVECs (Figure 7A, top) . As an internal control, an equal amount of each cDNA was assayed by PCR using human ␤-actin primers (Figure 7A, bottom) . The identity of the PCR products was further confirmed by sequencing (data not shown). Ang1 protein is detected in culture medium from HUVSMCs but not from HUVECs ( Figure 7B ). Immunohistochemical analysis indicated that Ang1 protein is mainly located in perivascular or muscular, but not endothelial, areas of blood vessels (Figure 8 ). These results indicate that Ang1 probably exerts its antiapoptotic effect on endothelial cells by paracrine action.
Discussion
Although the significance of Ang1 and its endothelial cellspecific receptor, Tie2, in vasculogenesis is well established, the signal transduction cascades initiated by the binding of Ang1 to the Tie2 receptor have not been characterized. Jones and Dumont 26 isolated a novel Tie2 receptor-interacting protein, Dok-R, that is a novel docking protein. Dok-R is the first downstream substrate of the activated Tie2 receptor and is constitutively bound to Crk. This result suggests that Tie2 may have multiple signaling pathways. A recent study indicates that Tie2 activates PI 3Ј-kinase through an association with the p85 regulatory unit. 20 Although these findings have been observed without Ang1 stimulation, this result suggests that Ang1 can activate PI 3Ј-kinase through Tie2 binding. Our results demonstrate that Ang1 induced phosphorylation of the Tie2 receptor and p85 subunit of PI 3Ј-kinase and increased the activity of PI 3Ј-kinase in HUVECs. The Ang1-induced antiapoptotic effect was reversed by soluble Tie2 receptor or PI 3Ј-kinase inhibitors. Therefore, the signaling pathway between Tie2 and PI 3Ј-kinase is an essential step for an Ang1-induced antiapoptotic effect in endothelial cells. The serine-threonine protein kinase Akt 27 is a downstream effector of PI 3Ј-kinase. Activation of PI 3Ј-kinase increases the intracellular amount of phosphatidylinositol-4,5-biphosphate and phosphatidylinositol-3,4,5-triphosphate, which positively regulate Akt. Thus, Akt is activated by phospholipid binding and phosphorylation within the activation loop at Thr308 and within the COOH terminus at Ser473. 28 The PI 3Ј-kinase and Akt pathways are common features in the signal transduction of the antiapoptotic effects of growth factors. 19 In this study, we demonstrate that Ang1 induces Akt phosphorylation at Ser473, and this induction is PI 3Ј-kinase dependent. In addition, our findings indicated that inactivation of Akt reversed the Ang1induced antiapoptotic effect in endothelial cell lines. Thus, Ang1-induced PI 3Ј-kinase activation and Akt phosphorylation could be crucial steps in the antiapoptotic effect of Ang1 on endothelial cells. Interestingly, VEGF is also a strong survival factor in endothelial cells under serum deprivation, and it also induces PI 3Ј-kinase activation and Akt phosphorylation. 29 Thus, Ang1 and VEGF have a common intracellular second messenger signaling pathway for preventing apoptosis in endothelial cells under serum deprivation. Recently, Akt has been shown to promote cell survival or nitric oxide production through its ability to phosphorylate Bad 30 and procaspase-9 31 or endothelial nitric oxide synthase. 32, 33 Thus, the downstream pathways and processes following from Ang1-induced Akt phosphorylation in endothelial cells will be examined in future studies.
Although Ang1 is mainly synthesized in periendothelial cells, including vascular smooth muscle cells, 8,10 its receptor, Tie2, is mainly located in the endothelial cells of normal adult vessels in which vasculogenesis or angiogenesis is not occurring. 25 Thus, we reach 2 conclusions. First, Ang1 may serve a cell survival function in nonproliferating endothelial cells. Second, Ang1 may be a paracrine factor. Our RT-PCR and immunohistochemical analyses indicate that Ang1 mRNA and protein are present in vascular smooth muscle cells but not in the endothelial cells where it is active. In addition, Ang1 is detected in culture medium from HUVSMCs but not from HUVECs. These facts suggest that Ang1 has a paracrine activity. The constitutive expression of Ang1 in vascular smooth muscle cells suggests that it may be involved in endothelial cell survival. This survival effect may help to maintain endothelial tissue integrity.
In summary, we found a receptor/signal transduction pathway by which Ang1 promotes the survival of endothelial cells. Our results indicate that the Tie2 receptor and the PI 3Ј-kinase/Akt signal transduction pathway are crucial elements in the processes leading to endothelial cell survival induced by the paracrine activity of Ang1.
